scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/jcisd/SegallCLLMS11 |
P356 | DOI | 10.1021/CI2003208 |
P8608 | Fatcat ID | release_33gb4ssj5bb7zcmrha4lsakt2q |
P698 | PubMed publication ID | 21981548 |
P2093 | author name string | Matthew Segall | |
Brian Stevens | |||
Ryan Lilien | |||
Chris Leeding | |||
Ed Champness | |||
Ramgopal Mettu | |||
P2860 | cites work | DrugBank: a knowledgebase for drugs, drug actions and drug targets | Q24650300 |
SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules | Q28090714 | ||
ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr | Q33384498 | ||
P433 | issue | 11 | |
P304 | page(s) | 2967-2976 | |
P577 | publication date | 2011-10-18 | |
P1433 | published in | Journal of Chemical Information and Modeling | Q3007982 |
P1476 | title | Applying medicinal chemistry transformations and multiparameter optimization to guide the search for high-quality leads and candidates. | |
P478 | volume | 51 |
Q26781471 | A Role for Fragment-Based Drug Design in Developing Novel Lead Compounds for Central Nervous System Targets |
Q41363342 | A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discovery |
Q38209075 | Advances in multiparameter optimization methods for de novo drug design |
Q39226854 | Alternative variables in drug discovery: promises and challenges |
Q39423618 | Analyzing compound and project progress through multi-objective-based compound quality assessment. |
Q38167262 | Chemical predictive modelling to improve compound quality |
Q28829404 | Computational prediction and validation of an expert's evaluation of chemical probes |
Q39664353 | The errors of our ways: taking account of error in computer-aided drug design to build confidence intervals for our next 25 years |
Search more.